Kiadis Pharma is a cross-Atlantic oncology focused biopharmaceutical development company with products in different phases of clinical development.
The company develops products that offer novel treatment options for terminally ill cancer patients and addresses high unmet medical needs. The key focus of Kiadis Pharma is to overcome current limitations and complications of bone marrow transplantation procedures for the treatment of blood cancer patients.
Kiadis Pharma is headquartered in Amsterdam, the Netherlands and has additional facilities in Groningen, the Netherlands and Montreal, Canada.
This site informs about the products in development, clinical programs, platform technologies and partners that will enable Kiadis Pharma to realize its ambitions.
Manja Bouman, CEO
The company develops products that offer novel treatment options for terminally ill cancer patients and addresses high unmet medical needs. The key focus of Kiadis Pharma is to overcome current limitations and complications of bone marrow transplantation procedures for the treatment of blood cancer patients.
Kiadis Pharma is headquartered in Amsterdam, the Netherlands and has additional facilities in Groningen, the Netherlands and Montreal, Canada.
This site informs about the products in development, clinical programs, platform technologies and partners that will enable Kiadis Pharma to realize its ambitions.
Manja Bouman, CEO
